Emily S. Tonorezos, MD, MPH

Office of Cancer Survivorship

Emily S. Tonorezos, MD, MPH, serves as Director of the Office of Cancer Survivorship, part of the Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI). In this position, Dr. Tonorezos leads NCI’s efforts to address the challenges facing cancer survivors and their families -- to prevent or mitigate adverse effects and to improve the health and well-being of cancer survivors from the time of diagnosis through the remainder of their lives.

Dr. Tonorezos came to NCI from Memorial Sloan Kettering Cancer Center and the Weill Cornell Medical College, both in New York, NY, where she served as Director of the Adult Long-Term Follow-Up Program for survivors of childhood and young adult cancers. Her research focuses on cardiometabolic consequences of cancer therapy, childhood and young adult cancer survivorship, diet and nutrition, and care coordination for this population. She serves on the National Academy of Sciences, Engineering and Medicine Committee on Childhood Cancer and Disability; the Cancer Survivorship Committee, the Adolescent and Young Adult Task Force, and the Clinical Guideline Committee for the American Society of Clinical Oncology (ASCO); and the Metabolic Syndrome Guideline Committee for the Children’s Oncology Group (COG). She is currently co-leader of the International Guideline Harmonization Group for the metabolic syndrome and led a recent international effort to develop recommendations for adult survivors of heritable retinoblastoma.

Dr. Tonorezos is a general internist, having earned her medical degree from the University of Rochester School of Medicine and masters in public health from the Johns Hopkins Bloomberg School of Public Health. She completed internal medicine residency and chief residency at Columbia University Medical Center, as well as a general internal medicine fellowship at the Johns Hopkins Hospital.

Last Updated
September 24, 2020